Your browser doesn't support javascript.
loading
Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse Models.
Jeon, Min Ji; Haugen, Bryan R.
Afiliación
  • Jeon MJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Haugen BR; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Endocrinol Metab (Seoul) ; 37(6): 830-838, 2022 12.
Article en En | MEDLINE | ID: mdl-36604954
ABSTRACT
The overall prognosis of thyroid cancer is excellent, but some patients have grossly invasive disease and distant metastases with limited responses to systemic therapies. Thus, relevant preclinical models are needed to investigate thyroid cancer biology and novel treatments. Different preclinical models have recently emerged with advances in thyroid cancer genetics, mouse modeling and new cell lines. Choosing the appropriate model according to the research question is crucial to studying thyroid cancer. This review will discuss the current preclinical models frequently used in thyroid cancer research, from cell lines to mouse models, and future perspectives on patient-derived and humanized preclinical models in this field.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Adenocarcinoma Folicular Límite: Animals Idioma: En Revista: Endocrinol Metab (Seoul) Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Adenocarcinoma Folicular Límite: Animals Idioma: En Revista: Endocrinol Metab (Seoul) Año: 2022 Tipo del documento: Article